These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4146876)

  • 1. Sectral in the management of angina pectoris.
    Lewis BS; Bakst A; Kitchiner DJ; Gotsman MS
    S Afr Med J; 1973 Aug; 47(32):1455-9. PubMed ID: 4146876
    [No Abstract]   [Full Text] [Related]  

  • 2. Practolol in patients with angina pectoris.
    Alderman EL; Davis RO; Friedman JP; Graham AF; Matlof HJ; Harrison DC
    Clin Pharmacol Ther; 1973; 14(2):175-81. PubMed ID: 4144425
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man.
    Lewis BS; Bakst A; Kitchiner D; Gotsman MS
    S Afr Med J; 1973 Jul; 47(27):1181-4. PubMed ID: 4146564
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of practolol on angina pectoris induced by atrial pacing.
    Gavrilescu S; Streian C; Pop T
    Cor Vasa; 1972; 14(4):259-64. PubMed ID: 4146675
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A).
    Lewis BS; Bakst A; Mitha AS; Purdon K; Gotsman MS
    Br Heart J; 1973 Jul; 35(7):743-51. PubMed ID: 4146280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
    Willems D; Frisch P; Klepzig H
    Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
    [No Abstract]   [Full Text] [Related]  

  • 7. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of adrenergic beta-blocking drugs in angina pectoris.
    Sharma B; Meeran MK; Galvin MC; Tulpule AT; Whitaker W; Taylor SH
    Br Med J; 1971 Jul; 3(5767):152-5. PubMed ID: 4397655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of adrenergic beta-receptor antagonists in angina pectoris.
    Thadani U; Sharma B; Meeran MK; Majid PA; Whitaker W; Taylor SH
    Br Med J; 1973 Jan; 1(5846):138-42. PubMed ID: 4145234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the symptomatic, electrocardiographic and haemodynamic effects of acute and long term -blockade in angina pectoris.
    Sharma B; Taylor SH
    Br J Pharmacol; 1971 Oct; 43(2):470P-471P. PubMed ID: 4400578
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of beta sympatholytic agent ICI 50172 (Dalzic) in various cardiovascular diseases].
    Müller H; Barthels F; Kluthe R
    Med Klin; 1973 May; 68(19):634-41. PubMed ID: 4125216
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodynamic studies on the beta receptor blockader Kö 592 under rest and under exertion].
    Deibert K; Steim H; Heinrich K; Siller K
    Med Klin; 1972 Jun; 67(24):845-9. PubMed ID: 4403610
    [No Abstract]   [Full Text] [Related]  

  • 13. Respiratory effects of acebutolol hydrochloride.
    Leary WP; Coleman AJ; Asmal AC
    S Afr Med J; 1973 Jul; 47(28):1245-8. PubMed ID: 4146466
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic and electrocardiographic effects of practolol during upright exercise in coronary heart disease.
    Rousseau MF; Brasseur LA; Detry JM
    Cardiovasc Res; 1973 May; 7(3):306-12. PubMed ID: 4146653
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectoris.
    Sood NK; Havard CW
    Thorax; 1973 May; 28(3):331-4. PubMed ID: 4146782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New adrenergic beta receptor blockader: practolol. Its effect in the treatment of coronary insufficiency].
    Bohyn P; De Mey D; Dernier J
    Acta Cardiol; 1972; Suppl 16():87-101. PubMed ID: 4405747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICI 50172) in coronary insufficiency. Preliminary results].
    Rousseau M; Vandenput F; Brasseur L
    Acta Cardiol; 1972; ():Suppl 15:239-54. PubMed ID: 4404471
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamic effects of a cardioselective beta-adrenergic inhibitor (ICI 50172) in coronary insufficiency. Preliminary results].
    Rosseau M; Vandenput F; Brasseur L
    Acta Cardiol; 1972; ():Suppl 15: 239-. PubMed ID: 4147615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.